Interleukin-17 (IL-17) is involved in host defense against
bacterial infection. Little is known about the role of
IL-17 in A. baumannii-infected
pneumonia. Our objective was to investigate the role of
IL-17 in pulmonary A. baumannii
infection in a mouse model. We infected C57BL/6 mice intra-tracheally (i.t.) with A. baumannii to establish
pneumonia model and found A. baumannii
infection elevated
IL-17 expression in lungs. IL-17-deficient (Il17-/-) mice were resistant to pulmonary A. baumannii
infection, showing improved mice survival, reduced bacteria burdens, and alleviated
lung inflammation. Further, treatment of A. baumannii-infected Il17-/- mice with
IL-17 exacerbated the severity of
pneumonia. These data suggest a pathogenic role of
IL-17 in pulmonary A. baumannii
infection. Further, the infiltration and phagocytic function of neutrophils in broncho-alveolar lavage fluid were detected by flow cytometry. The results showed that Il17-/- mice had increased neutrophil infiltration and enhanced phagocytosis in neutrophils at the early time of
infection. Treatment of mice with
IL-17 suppressed phagocytic function of neutrophils. All data suggest that
IL-17 promotes susceptibility of mice to pulmonary A. baumannii
infection by suppressing neutrophil phagocytosis at early time of
infection. Targeting
IL-17 might be a potential therapeutic strategy in controlling the outcome of A. baumannii pneumonia.